Interleukin-2 therapies have been seen as promising ways to treat solid tumors, but they have proven challenging because of the ability of IL-2 to both activate and suppress the immune system. Their effectiveness has been limited because of potentially toxic side effects, which have included vascular leak syndrome and pulmonary edema. Aulos Biosciences believes the AI-based approach to computational drug design used for its lead experimental therapy allows it to unlock the power of IL-2 without triggering the concerning side effects of existing therapies. We spoke to Aron Knickerbocker, president and CEO of Aulos Bioscience, about the potential for IL-2 therapies to treat solid tumors, the limits of today's IL-2 therapies, and the AI-based design behind its experimental IL-2 therapy in development.
A Nonprofit Seeks to Make Cell and Gene Therapies Affordable Worldwide
Disposing Toxic Proteins to Treat Neurodegenerative Diseases
Repurposing a Drug for Parasitic Infections as a Targeted GI Therapy
Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging
The Year in Biotech and What’s Ahead in 2022
Restoring the Guardian of the Genome to Fight Tumors
Advancing a Cell Therapy with the Potential to Cure HIV
Harnessing More Efficient Organisms to Reshore BioManufacutring
Using Digital Health Technology to Bring the Trial to the Patient
Using the Body’s Housecleaning Mechanism to Target Undruggable Proteins
Advocating for the Extension of Healthy Life
Using Donated Living Skin as an Alternative to Animal Testing
A Platform to Scale the Production of Personalized Cell Therapies
Developing Small Molecule Therapies to Target Proteins Only Biologics Have Been Able to Hit
Targeting Solid Tumors with Oncolytic Viruses
Reinventing the Discovery and Cell Line Development of Biotherapeutics
Engineering Off-the-Shelf Cell Therapies to Target Solid Tumors
Democratizing Drug Discovery
Scaling Genetic Counseling Services with AI
Programming Cell Therapies to Overcome Solid Tumor Defense Systems
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Speaking of Psychology
Stuff To Blow Your Mind